We are excited to be participating in the European Society for Medical Oncology (ESMO) 2024 Congress 2024 from September 13-17 in Barcelona. During the meeting, a late-breaking abstract from the IGNYTE clinical trial primary analysis will be presented during an oral session #ESMO #Melanoma Read more: https://lnkd.in/exb9TN-P
Replimune’s Post
More Relevant Posts
-
The Scientific Program Committee and American Society of Clinical Oncology (ASCO) Leadership selected our Trials in Progress abstract for presentation in a poster session! Meet our team to discuss our ongoing clinical trial. Date and Time: Saturday, June 1, 9:00 AM - 12:00 PM Abstract Number: TPS3171 Abstract Title: A phase 1, first-in-human, open-label study evaluating the safety, tolerability, pharmacokinetics, and efficacy of TT125-802 in patients with advanced solid tumors. #ASCO24 #StoppingCancerDrugResistance
-
-
Consultant in the department of Gynecological oncology in Amrita with special interest in ROBOTIC, HIPEC, PIPAC .
#oncology https://lnkd.in/gpd3J-Bg Abstract presentation at the Young leaders in Oncology session.
-
A week has passed since ESMO 2024! What were your highlights? Check out Diaceutics PLC's article summarizing some key advancements for precision oncology: https://lnkd.in/e9FHHjnf #ESMO24 #BetterTestingBetterTreatment
DXRX - ESMO 2024 Highlights
dxrx.io
-
Today, we announced a poster presentation at the American Society of Clinical Oncology (ASCO)) annual meeting highlighting interim results from the ongoing Phase 1 ELiPSE-1 study of CNTY-101 in relapsed or refractory (R/R) #lymphoma. The poster showcases CNTY-101’s continued encouraging preliminary efficacy and manageable safety profile for with no observed DLTs or GvHD. Learn more: https://bit.ly/3RaEI3k #ASCO2024
-
-
Early/Late Phase and Regulatory Strategy, RWE & RWD, Market Access, Logistics at Parexel Biotech
In the next blog in our oncology series, Parexel experts outline a proven 4-part approach to understanding and integrating the patient perspective and how it can guide study design and improve outcomes. Our dedicated team of Biotech experts will amplify your team’s expertise to help you uncover insights faster to impact patient lives. Let’s change lives together. #OncologyResearch #PatientPerspective #ClinicalTrials #ParexelBiotech
Patient-guided oncology trials: Why the patient perspective is essential to success :: Parexel
share.parexel.social
-
In the next blog in our oncology series, Parexel experts outline a proven 4-part approach to understanding and integrating the patient perspective and how it can guide study design and improve outcomes. Our dedicated team of Biotech experts will amplify your team’s expertise to help you uncover insights faster to impact patient lives. Let’s change lives together. #OncologyResearch #PatientPerspective #ClinicalTrials #ParexelBiotech
Patient-guided oncology trials: Why the patient perspective is essential to success :: Parexel
share.parexel.social
-
Business Development Manager @ Parexel | Sales Target Management | French, Spanish, English speaker
In the next blog in our oncology series, Parexel experts outline a proven 4-part approach to understanding and integrating the patient perspective and how it can guide study design and improve outcomes. Our dedicated team of Biotech experts will amplify your team’s expertise to help you uncover insights faster to impact patient lives. Let’s change lives together. #OncologyResearch #PatientPerspective #ClinicalTrials #ParexelBiotech
Patient-guided oncology trials: Why the patient perspective is essential to success :: Parexel
share.parexel.social
-
In the next blog in our oncology series, Parexel experts outline a proven 4-part approach to understanding and integrating the patient perspective and how it can guide study design and improve outcomes. Our dedicated team of Biotech experts will amplify your team’s expertise to help you uncover insights faster to impact patient lives. Let’s change lives together. #OncologyResearch #PatientPerspective #ClinicalTrials #ParexelBiotech
Patient-guided oncology trials: Why the patient perspective is essential to success :: Parexel
share.parexel.social
-
In the next blog in our oncology series, Parexel experts outline a proven 4-part approach to understanding and integrating the patient perspective and how it can guide study design and improve outcomes. Our dedicated team of Biotech experts will amplify your team’s expertise to help you uncover insights faster to impact patient lives. Let’s change lives together. #OncologyResearch #PatientPerspective #ClinicalTrials #ParexelBiotech
Patient-guided oncology trials: Why the patient perspective is essential to success :: Parexel
share.parexel.social
-
In the next blog in our oncology series, Parexel experts outline a proven 4-part approach to understanding and integrating the patient perspective and how it can guide study design and improve outcomes. Our dedicated team of Biotech experts will amplify your team’s expertise to help you uncover insights faster to impact patient lives. Let’s change lives together. #OncologyResearch #PatientPerspective #ClinicalTrials #ParexelBiotech
Patient-guided oncology trials: Why the patient perspective is essential to success :: Parexel
share.parexel.social
